Cargando…

RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial

BACKGROUND: Treatment for locally advanced rectal cancer (LARC) consists of chemoradiation therapy (CRT) and surgery. Approximately 15% of patients show a pathological complete response (pCR). Increased pCR-rates can be achieved through dose escalation, thereby increasing the number patients eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burbach, JP Maarten, Verkooijen, Helena M, Intven, Martijn, Kleijnen, Jean-Paul JE, Bosman, Mirjam E, Raaymakers, Bas W, van Grevenstein, Wilhelmina MU, Koopman, Miriam, Seravalli, Enrica, van Asselen, Bram, Reerink, Onne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344756/ https://www.ncbi.nlm.nih.gov/pubmed/25888548 http://dx.doi.org/10.1186/s13063-015-0586-4

Ejemplares similares

Does setup on rectal wall improve rectal cancer boost radiotherapy?
por: Kleijnen, Jean-Paul J. E., et al.
Publicado: (2018)

Timing of rectal cancer surgery after short-course radiotherapy: national database study
por: Verweij, Maaike E, et al.
Publicado: (2023)

Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
por: Hoendervangers, S., et al.
Publicado: (2020)

Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial
por: Guido, Alessandra, et al.
Publicado: (2022)

Qualitative Approximations to Causality: Non-Randomizable Factors in Clinical Psychology
por: Höfler, Michael, et al.
Publicado: (2021)

ATIVS: analytical tool for influenza virus surveillance
por: Liao, Yu-Chieh, et al.
Publicado: (2009)

Patient‐ and physician‐reported radiation‐induced toxicity of short‐course radiotherapy with a prolonged interval to surgery for rectal cancer
por: Verweij, Maaike E., et al.
Publicado: (2022)

Online Adaptive MRI-Guided Radiotherapy for Primary Tumor and Lymph Node Boosting in Rectal Cancer
por: Kensen, Chavelli M., et al.
Publicado: (2023)

A RandomizEd trial of ENtERal Glutamine to minimIZE thermal injury (The RE-ENERGIZE Trial): a clinical trial protocol
por: Heyland, Daren K., et al.
Publicado: (2017)

Cre-ativity in the liver: Transgenic approaches to targeting hepatic nonparenchymal cells
por: Greenhalgh, Stephen N, et al.
Publicado: (2015)

Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost
por: Zhao, Jun, et al.
Publicado: (2015)

A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients
por: Wu, Hao, et al.
Publicado: (2016)

Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer
por: Yang, Yongqiang, et al.
Publicado: (2019)

1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation
por: Bonomo, Pierluigi, et al.
Publicado: (2020)

BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial
por: Opbroek, Thirza J.S., et al.
Publicado: (2022)

Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study
por: Engels, Benedikt, et al.
Publicado: (2023)

The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes
por: Meldolesi, Elisa, et al.
Publicado: (2022)

MR-Guided Radiotherapy for Rectal Cancer: Current Perspective on Organ Preservation
por: Boldrini, Luca, et al.
Publicado: (2021)

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)
por: Wang, Jingwen, et al.
Publicado: (2019)

The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial
por: Liu, Wen-Yang, et al.
Publicado: (2022)

Radiation boost for synchronous solitary inguinal lymph node metastasis during neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Chen, Mo, et al.
Publicado: (2021)

Logistic random forest boosting technique for Alzheimer’s diagnosis
por: Shastry, K. Aditya, et al.
Publicado: (2023)

Random RotBoost: An Ensemble Classification Method Based on Rotation Forest and AdaBoost in Random Subsets and Its Application to Clinical Decision Support
por: Lee, Shin-Jye, et al.
Publicado: (2022)

Rectal diclofenac versus high-dose rectal acetaminophen in children: A randomized clinical trial
por: Hashemian, Houman, et al.
Publicado: (2021)

The impact of retractor SPONGE-assisted laparoscopic surgery on duration of hospital stay and postoperative complications in patients with colorectal cancer (SPONGE trial): study protocol for a randomized controlled trial
por: Couwenberg, Alice M., et al.
Publicado: (2016)

Interstitial high-dose-rate brachytherapy as a boost in synchronous prostate and rectal cancer treatment: case report and literature review
por: Konat-Bąska, Katarzyna, et al.
Publicado: (2020)

Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers
por: Osman, Sarah O. S., et al.
Publicado: (2022)

Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Rectal Cancer: Long-Term Results after Protocol-Based Treatment
por: Lee, Dong Soo, et al.
Publicado: (2022)

The Mycorrizal Status in Vineyards Affected by Esca
por: Landi, Lucia, et al.
Publicado: (2021)

Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study
por: Zhu, Ji, et al.
Publicado: (2014)

Neoadjuvant volumetric modulated arc radiochemotherapy with a simultaneous integrated boost technique compared to standard chemoradiation for locally advanced rectal cancer
por: JANKARASHVILI, Natalia, et al.
Publicado: (2019)

Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation
por: Zhou, Han, et al.
Publicado: (2023)

“ISA-Lation” of Single-Stranded Positive-Sense RNA Viruses from Non-Infectious Clinical/Animal Samples
por: Aubry, Fabien, et al.
Publicado: (2015)

Proyecto de inversión: Agencia de Tráfico Internacional de Transportación Marítima "ATIVER, S.C." /
por: Martínez González, María Magdalena
Publicado: (2000)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

The IMpact of PerioperAtive KeTamine on Enhanced Recovery after Abdominal Surgery (IMPAKT ERAS): protocol for a pragmatic, randomized, double-blinded, placebo-controlled trial
por: Raymond, Britany L., et al.
Publicado: (2023)

The IMpact of PerioperAtive KeTamine on Enhanced Recovery after Abdominal Surgery (IMPAKT ERAS): protocol for a pragmatic, randomized, double-blinded, placebo-controlled trial
por: Raymond, Britany L., et al.
Publicado: (2023)

Preoperative Intensity-modulated Chemoradiation Therapy with Simultaneous Integrated Boost in Rectal Cancer: 2-year Follow-up Results of Phase II Study
por: But-Hadzic, Jasna, et al.
Publicado: (2018)

Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer
por: Bae, Bong Kyung, et al.
Publicado: (2017)

Preoperative Intensity-modulated Chemoradiotherapy with Simultaneous Integrated Boost in Rectal Cancer: Five-year Follow-up Results of a Phase II Study
por: But-Hadzic, Jasna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rhig6oh24nkbjupmten38ge9nf